Unbiased AI-powered news
8 stories related to this topic, newest first.
French drugmaker Ipsen will buy U.S.-based Kartos Therapeutics, which is developing a treatment for a rare blood cancer. The deal is Ipsen’s second acquisition this week.
middleeasteye.netU.S. and Iranian negotiators said they made progress toward a deal within 60 days and set up a communication line for the Strait of Hormuz. UK Prime Minister Keir Starmer announced his resignation, clearing the way for a Labour leadership contest by September.
etftrends.comPharmaceutical and large biotech firms spent about $123 billion on 32 deals of $1 billion or more in the six months through June 22, 2026. The total exceeds the $112 billion spent on 26 similar deals in all of 2025.
rte.ieThe private equity firm is postponing the sale after prospective investors raised concerns about artificial intelligence disrupting the legal-tech sector.
Major U.S. indexes posted gains on June 11, 2026, while several companies reported earnings and announced deals or offerings that moved their shares sharply.
BenzingaTransaction value increased from $283 billion a year earlier even as the number of deals reached its lowest level in several years.
Jasper Therapeutics, Dot AI, and America's Car-Mart each launched reviews of strategic alternatives this week. New Mountain Capital closed a $2 billion-plus purchase of Asset Living.
benzinga.comPMGC Holdings Inc. announced a non-binding letter of intent to acquire a 76% controlling interest in an Arizona-based precision machining company founded in 2006. The target generated $5.46 million in revenue and $1.05 million in EBITDA for fiscal year 2025.